Target intelligence / Profile preview

Variant U1 Small Nuclear RNA 17 (RNVU1-17)

Target
RNVU1-17
Molecular classification
Small nuclear RNA (snRNA), Non-coding RNA, Spliceosomal RNA, Other (structural RNA)
01

Overview

Variant U1 Small Nuclear RNA 17 (RNVU1-17) is a non-coding RNA gene encoding a small nuclear RNA (snRNA) closely related to canonical U1 snRNA. It participates in pre-mRNA splicing, binding to the 5′ splice site and facilitating the assembly of the spliceosome complex in the nucleus[2][1]. Variant U1 snRNAs display high sequence similarity to canonical U1 snRNAs but may carry unique mutations or exist in variable copy numbers due to segmental duplications and genomic rearrangements[2]. The exact functionality of each variant (including RNVU1-17) may differ due to alterations in promoter or gene body sequences, with genome annotation updates potentially changing locus identification[2]. Although U1 snRNA family members are essential for cell viability and gene expression, variant loci like RNVU1-17 are not currently recognized as therapeutic targets or biomarkers, and their direct implication in disease is unclear. The assessment of mutations and copy number variation for these snRNAs presents technical challenges given their repetitive genomic context, especially for disease association studies[2].

Other names
vU1.17RNU1-127RNVU1-17
02

Biological functions

Pre-mRNA splicing: Binds the 5' splice site of pre-mRNA, participates in spliceosome assemblyRegulation of alternative polyadenylation: Non-canonical roles in alternative mRNA transcript processingRNA-protein complex formation: Component of U1 snRNP and helps with recruiting protein cofactors
03

Disease associations

Other (genomic copy number variability and mutations in variant U1 snRNA genes are found, but direct clinical disease roles for RNVU1-17 itself are not confirmed; broader U1 snRNA mutations have been associated with neurological and developmental disorders, and potentially some cancers, but specific links to this variant are not established)

Beyond the preview

Go deeper on Variant U1 Small Nuclear RNA 17 (RNVU1-17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Variant U1 Small Nuclear RNA 17 (RNVU1-17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call